Drug-labels.com

Atrovent Nasal Spray: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
21 mcg, 42 mcg
Active ingredient:
Similar drugs:

Patient Medication Information: uses, side effects, how to take - Atrovent Nasal Spray

ABOUT THIS MEDICATION

What the medication is used for:

ATROVENT Nasal Spray 0.03% is used to treat the runny nose associated with perennial allergic or nonallergic rhinitis.

ATROVENT Nasal Spray 0.06% is used to treat the runny nose associated with the common cold.

ATROVENT Nasal Spray is intended to relieve your rhinorrhea (runny nose) with regular use. It is therefore important that you use ATROVENT Nasal Spray as prescribed by your physician. Some improvement in rhinorrhea is usually apparent during the first full day of treatment with ATROVENT Nasal Spray. However, maximum benefit may not occur for up to several weeks after treatment has started.

What it does:

ATROVENT Nasal Spray works to stop the glands in your nose from producing excessive nasal secretions. ATROVENT Nasal Spray must be prescribed by a doctor.

When it should not be used:

ATROVENT Nasal Spray should not be used by patients with a history of allergy to ipratropium bromide, or to any component of this formulation.

ATROVENT Nasal Spray should not be used by patients with allergic reaction to ipratropium bromide, atropinics (atropine or atropine-like drugs) or to any component of the drug (See What the non-medicinal ingredients are).

What the medicinal ingredient is:

ipratropium bromide

What the non-medicinal ingredients are:

Benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, sodium hydroxide and purified water.

What dosage forms it comes in:

ATROVENT Nasal Spray 0.03% w/v

ATROVENT Nasal Spray 0.06% w/v

WARNINGS AND PRECAUTIONS

BEFORE you use ATROVENT Nasal Spray talk to your doctor or pharmacist if:

  • you are pregnant or intend to become pregnant;

  • you are breast feeding;
  • you have any other health problems, now or in the past;
  • you have eye problems, such as predisposition to glaucoma;
  • you have difficulty/trouble urinating or problems with your prostate;
  • you are taking any other medications including eye drops or any medications you can buy without prescription;
  • you have any allergies or reactions to foods or drugs.

ATROVENT Nasal Spray may cause dizziness, difficulty in focusing the eyes, dilated pupils, and blurred vision. You should not drive or operate machinery if this occurs.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with ATROVENT Nasal Spray include: Other anticholinergic drugs.

PROPER USE OF THIS MEDICATION

For adults and children over 12 years of age.

1.
Remove the clear plastic dust cap and the safety clip from the nasal spray pump. The safety clip prevents the accidental discharge of the spray in your pocket or purse.
2.
The nasal spray pump must be primed before ATROVENT Nasal Spray is used for the first time. To prime the pump, hold the bottle with your thumb at the base and your index and middle fingers on the white shoulder area. Make sure the bottle points upright and away from your eyes. Press your thumb firmly and quickly against the bottle seven times. The pump is now primed and can be used. Your pump should not have to be reprimed unless you have not used the medication for more than 24 hours; repriming the pump will only require one or two sprays.
  1. 3. Before using ATROVENT Nasal Spray, blow your nose gently to clear your nostrils if necessary.
4.
Close one nostril by gently placing your finger against the side of your nose, tilt your head slightly forward and, keeping the bottle upright, insert the nasal tip into the other nostril. Point the tip toward the back and outer side of the nose.
  1. 5. Press firmly and quickly upwards with the thumb at the base while holding the white shoulder portion of the pump between your index and middle fingers. Following each spray, sniff deeply and breathe out through your mouth.
  2. 6. After spraying the nostril and removing the unit, tilt your head backwards for a few seconds to let the spray spread over the back of the nose.
  3. 7. Repeat steps 4 through 6 in the other nostril.
  4. 8. Replace the clear plastic dust cap and safety clip.
  5. 9.

    When the amount of ATROVENT Nasal Spray begins to run low, the amount of medication in each spray cannot be assured. Therefore, at some time before the medication is completely used up, you should consult your physician or pharmacist to

    • determine whether a refill is needed. You should not take extra doses of ATROVENT Nasal Spray without consulting your physician.

To Clean:

If the nasal tip becomes clogged, remove the clear plastic dust cap and safety clip. Hold the nasal tip under running warm tap water for about a minute. Dry the nasal tip, reprime the nasal spray pump (step 2 above), and replace the plastic dust cap and safety clip.

Avoid spraying ATROVENT Nasal Spray in or around your eyes. Should this occur, immediately flush your eyes with cool tap water for several minutes. If you accidentally

spray ATROVENT Nasal Spray in your eyes, you may experience a temporary blurring of vision and increased sensitivity to light, which may last a few hours.

Do not exceed the number of sprays, or the length of use, prescribed by your doctor.

ATROVENT Nasal Spray has been prescribed to treat your current condition. Do not give it to other people.

Do not take other medication without your doctor’s advice.

Overdose:

In case of drug overdose, contact a healthcare practitioner, hospital emergency department or regional poison control centre, even if there are no symptoms. Always take the labelled medicine container with you.

Missed Dose:

If you forget to take your dose, don’t worry. Take your next dose as usual. Do not double your dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like any other drug product, ATROVENT Nasal Spray may cause unwanted effects along with its good effects. If you do experience any of the unwanted effects listed below, you should contact your doctor. He/she may recommend that you lower your dose of ATROVENT Nasal Spray.

The most frequent side effects are headache, throat irritation, nasal discomfort, nasal dryness and nosebleeds.

Other side effects include: increased heart rate and a feeling that your heart is beating fast, heart problems such as fast or irregular heart beat ; eye disorders such as difficulty in focusing the eyes, seeing halos, swelling of the cornea, build up or increased pressure in the eye, dilated pupils, swelling of the blood vessels in the conjunctiva (outermost layer of the eye and inner surface of the eyelids), blurred vision, eye pain; difficulty in passing urine;

swelling of the muscles around the voice box; dry throat, dry mouth, swelling of the mouth and throat, increased wheezing or tightness in the chest or difficulty in breathing (bronchospasm) ; digestive problems like constipation, diarrhoea and vomiting; dizziness.

Some people can be allergic to medicines. If you have any of the following symptoms soon after taking ATROVENT Nasal Spray, stop taking this medicine and tell your doctor immediately or go the nearest hospital:

  • Sudden wheeziness and chest pain or tightness;
  • Sudden difficulty in breathing and reduction in your; blood pressure
  • Swelling of eyelids, face, tongue or throat;
  • Lumpy skin rash, or “hives” anywhere on the body.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
UncommonBlurred vision or pain in the eyesΤ
Fast or irregular heart beatΤ
Difficult or painful urinationΤ
RashΤ
Increased wheezing or tightness in the chest or difficulty in breathing (bronchospasm)Τ
Swelling of the tongue or lipsΤ
Difficulty in swallowingΤ

This is not a complete list of side effects. For any unexpected effects while taking ATROVENT Nasal Spray, contact your doctor or pharmacist.

HOW TO STORE IT

Store tightly closed between 15°C and 30°C. Avoid excessive heat or freezing. Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

--------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701D

      Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph (or prescribing information), prepared for health professionals can be found at:

www.sanofi.ca or by contacting the sponsor, sanofi-aventis Canada Inc., 1-800-265-7927. Please visit our website to see if more up-to-date information has been posted.

Last revised: June 29, 2017

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02163705

Revision date stated in the text: June 29, 2017

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Atrovent Nasal Spray

Rx or OTC
Prescription (Rx)?
DIN 02163705, 02163713
Schedule(s) PRESCRIPTION
Active ingredient(s) Ipratropium bromide
Dosage form(s) Solution
Route(s) of administration Nasal
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R01 Nasal preparations
      1. R01A Decongestants and other nasal preparations for topical use
        1. R01AX Other nasal preparations
          1. R01AX03 Ipratropium bromide
Company SANOFI-AVENTIS CANADA INC
Current status Cancelled Post Market
Current status date November 13, 2018
Strengths and forms
DIN Strength Dosage form(s) Current status
02163705 21 MCG Solution Cancelled Post Market November 13, 2018
02163713 42 MCG Solution Cancelled Post Market November 13, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.